Form 8-K
8-K — Pennant Group, Inc.
Accession: 0001766400-26-000053
Filed: 2026-05-06
Period: 2026-05-06
CIK: 0001766400
SIC: 8000 (SERVICES-HEALTH SERVICES)
Item: Results of Operations and Financial Condition
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — pntg-20260506.htm (Primary)
EX-99.1 (q12026earningspressrelease.htm)
GRAPHIC (pennantlogoa01a.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: pntg-20260506.htm · Sequence: 1
pntg-20260506
0001766400FALSE00017664002026-05-062026-05-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 6, 2026
The Pennant Group, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-38900 83-3349931
(State or other jurisdiction
of incorporation)
(Commission File Number) (IRS Employer Identification No.)
1675 E Riverside Drive, Suite 150,
Eagle, ID 83616
(Address of principal executive offices and Zip Code)
Registrant's telephone number, including area code: (208) 401-1400
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share PNTG Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On May 6, 2026, The Pennant Group, Inc. (the “Company”) issued a press release reporting the financial results of the Company for its first quarter ended March 31, 2026. A copy of the press release is attached to this Current Report as Exhibit 99.1.
Item 7.01. Regulation FD Disclosure.
The Company will post on its website an updated investor presentation for use at upcoming investor meetings. Please visit investor.pennantgroup.com to access the new presentation materials.
The information furnished pursuant to Item 2.02 and Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1
Press Release of the Company dated May 6, 2026.
104 Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 6, 2026
THE PENNANT GROUP, INC.
By: /s/ LYNETTE B. WALBOM
Lynette B. Walbom
Chief Financial Officer
EX-99.1
EX-99.1
Filename: q12026earningspressrelease.htm · Sequence: 2
Document
Exhibit 99.1
Pennant Reports First Quarter 2026 Results
Conference Call and Webcast scheduled for tomorrow, May 7, 2026 at 10:00 am MT
EAGLE, Idaho – May 6, 2026 (GLOBE NEWSWIRE) - The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.24 for the first quarter of 2026. Pennant also reported adjusted diluted earnings per share of $0.32 for the quarter(1).
First Quarter Highlights
▪Total revenue for the first quarter was $285.4 million, an increase of $75.5 million or 36.0% over the prior year quarter;
▪Net income for the first quarter was $8.5 million, a increase of $0.7 million or 9.6% over the prior year quarter;
▪Adjusted net income for the first quarter was $11.5 million, an increase of $1.9 million or 19.8% over the prior year quarter;
▪Consolidated Adjusted EBITDAR for the first quarter was $34.7 million, an increase of $6.7 million or 23.9% over the prior year quarter;
▪Consolidated Adjusted EBITDA for the first quarter was $21.7 million, an increase of $5.3 million or 32.6% over the prior year quarter;
▪Consolidated Adjusted EBITDA prior to NCI for the first quarter was $23.5 million, an increase of $6.4 million or 37.2% over the prior year quarter;
▪Home Health and Hospice Services segment revenue for the first quarter was $229.1 million, an increase of $69.2 million or 43.3% over the prior year quarter;
▪Home Health and Hospice Services segment adjusted EBITDAR from operations for the first quarter was $36.8 million, an increase of $9.5 million or 34.9% over the prior year quarter; and segment adjusted EBITDA from operations for the first quarter was $33.6 million, an increase of $8.5 million or 33.7% over the prior year quarter;
▪Total home health admissions for the first quarter were 30,721, an increase of 11,843 or 62.7% over the prior year quarter; total Medicare home health admissions for the first quarter were 13,303, an increase of 5,704 or 75.1% over the prior year quarter;
▪Hospice average daily census for the first quarter was 5,199, an increase of 1,405 or 37.0% compared to the prior year quarter;
1
▪Senior Living Services segment revenue for the first quarter was $56.3 million, an increase of $6.3 million or 12.6% over the prior year quarter; average occupancy for the first quarter was 78.6%, an increase of 10 basis points over the prior year quarter, and average monthly revenue per occupied room for the first quarter was $5,388, an increase of $195 or 3.8% over the prior year quarter;
▪Senior Living segment adjusted EBITDAR from operations for the first quarter was $16.3 million, an increase of $1.8 million or 12.6% over the prior year quarter; and segment adjusted EBITDA from operations for the first quarter was $6.4 million, an increase of $1.5 million or 30.6% over the prior year quarter.
(1)
See "Reconciliation of GAAP to Non-GAAP Financial Information.”
Operating Results
“Pennant is off to a strong start in 2026,” said Brent Guerisoli, the Company’s Chief Executive Officer. “After a year of dramatic expansion, we are driving operational excellence across both segments, including at our newly-acquired operations in the southeast, even as we complete their integration. That process is unfolding in line with our expectations, and we now have two of five waves of operations fully transitioned, leaders in place across the acquired agencies, and a total census above acquisition levels. When paired with the momentum in our mature businesses, we have the ingredients for a successful year.”
“Our mature operations continue to grow and deliver compelling results,” said John Gochnour, the Company’s Chief Operating Officer. “We have maintained rigor across our operations, where we are pushing for operational excellence at every level. Despite the heavy demands of integrating over 50 operations in the southeast and the headwinds of a 1.3% home health reimbursement cut, our same store margins improved, we saw strong year over year organic census and occupancy growth, and clinical outcomes continued to excel. As we continue to transition new operations and incrementally reduce duplicative expenses, we will unlock additional latent potential across our operations and drive margins toward our long term targets.”
A discussion of the Company’s use of Non-GAAP financial measures is set forth below. Reconciliations of net income to EBITDA, adjusted EBITDAR, adjusted EBITDA, and adjusted EBITDA prior to NCI, as well as a reconciliation of GAAP earnings per share, net income to adjusted net earnings per share and adjusted net income, appear in the financial data portion of this release. More complete information is contained in the Company’s Form 10-Q for the three months ended March 31, 2026, which will be filed with the SEC and will be available to be viewed on the Company’s website at www.pennantgroup.com.
Conference Call
A live webcast will be held tomorrow, May 7, 2026 at 10:00 a.m. Mountain time (12:00 p.m. Eastern time) to discuss Pennant’s first quarter 2026 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Pennant’s website at https://investor.pennantgroup.com. The webcast will be recorded and will be available for replay via the website.
About Pennant
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 174 home health and hospice agencies and 63 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice
2
businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.
These risks and uncertainties relate to the company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and/or 10-K, for a more complete discussion of the risks and other factors that could affect Pennant’s business, prospects and any forward-looking statements. Except as required by the federal securities laws, Pennant does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.
Contact Information
Investor Relations
The Pennant Group, Inc.
(208) 401-1400
ir@pennantgroup.com
SOURCE: The Pennant Group, Inc.
3
THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(unaudited, in thousands, except for per-share amounts)
Three Months Ended March 31,
2026 2025
Revenue $ 285,364 $ 209,842
Expense:
Cost of services 232,662 168,745
Rent—cost of services 13,098 11,715
General and administrative expense 19,687 14,840
Depreciation and amortization 2,616 1,892
Total expenses 268,063 197,192
Income from operations 17,301 12,650
Other expense, net:
Other expense (146) (69)
Interest expense, net (3,068) (1,205)
Other expense, net (3,214) (1,274)
Income before provision for income taxes 14,087 11,376
Provision for income taxes 3,794 2,854
Net income 10,293 8,522
Less: Net income attributable to noncontrolling interest 1,774 747
Net income attributable to The Pennant Group, Inc. $ 8,519 $ 7,775
Earnings per share:
Basic $ 0.25 $ 0.23
Diluted $ 0.24 $ 0.22
Weighted average common shares outstanding:
Basic 34,726 34,471
Diluted 35,757 35,202
4
THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except par value)
March 31, 2026 December 31, 2025
Assets
Current assets:
Cash $ 4,912 $ 17,024
Accounts receivable—less allowance for doubtful accounts of $701 and $681, at March 31, 2026 and December 31, 2025 respectively
122,820 123,109
Prepaid expenses and other current assets 25,092 27,273
Total current assets 152,824 167,406
Property and equipment, net 63,973 60,984
Operating lease right-of-use assets 273,179 275,947
Deferred tax assets, net 54 478
Restricted and other assets 29,766 26,676
Goodwill 237,246 237,246
Other indefinite-lived intangibles 199,442 199,442
Total assets $ 956,484 $ 968,179
Liabilities and equity
Current liabilities:
Accounts payable $ 22,798 $ 25,171
Accrued wages and related liabilities 40,303 65,229
Operating lease liabilities—current 25,557 25,013
Current maturities of long-term debt 5,000 5,000
Other accrued liabilities 34,917 26,851
Total current liabilities 128,575 147,264
Long-term operating lease liabilities—less current portion 251,258 254,311
Deferred tax liabilities, net 1,317 150
Other long-term liabilities 21,230 23,365
Long-term debt 164,668 168,837
Total liabilities 567,048 593,927
Commitments and contingencies
Equity:
Common stock, $0.001 par value; 100,000 shares authorized; 34,992 and 34,746 shares issued and outstanding at March 31, 2026, respectively; and 34,878 and 34,626 shares issued and outstanding at December 31, 2025, respectively
35 35
Additional paid-in capital 250,724 245,833
Retained earnings 95,319 86,800
Treasury stock, at cost, 3 shares at March 31, 2026 and December 31, 2025
(65) (65)
Total The Pennant Group, Inc. stockholders’ equity 346,013 332,603
Noncontrolling interest 43,423 41,649
Total equity 389,436 374,252
Total liabilities and equity $ 956,484 $ 968,179
5
THE PENNANT GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:
Three Months Ended March 31,
2026 2025
Net cash used in operating activities $ (3,405) $ (21,229)
Net cash used in investing activities (5,380) (50,301)
Net cash (used in) provided by financing activities (3,327) 52,505
Net decrease in cash (12,112) (19,025)
Cash beginning of period 17,024 24,246
Cash end of period $ 4,912 $ 5,221
6
THE PENNANT GROUP, INC.
REVENUE BY SEGMENT
(unaudited, dollars in thousands)
The following table sets forth our total revenue by segment and as a percentage of total revenue for the periods indicated:
Three Months Ended March 31,
2026 2025
Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage
Home health and hospice services
Home health $ 115,416 40.4 % $ 74,118 35.3 %
Hospice 99,159 34.7 70,586 33.6
Home care and other(a)
14,514 5.2 15,166 7.2
Total home health and hospice services 229,089 80.3 159,870 76.1
Senior living services 56,275 19.7 49,972 23.9
Total revenue $ 285,364 100.0 % $ 209,842 100.0 %
(a) Home care and other revenue is included with home health revenue in other disclosures in this press release.
7
THE PENNANT GROUP, INC.
SELECT PERFORMANCE INDICATORS
(unaudited, total revenue dollars in thousands)
The following table summarizes our overall home health and hospice performance indicators for the each of the dates or periods indicated:
Three Months Ended March 31,
2026 2025 Change % Change
Total agency results:
Home health and hospice revenue $ 229,089 $ 159,870 $ 69,219 43.3 %
Home health services:
Total home health admissions 30,721 18,878 11,843 62.7 %
Total Medicare home health admissions 13,303 7,599 5,704 75.1 %
Average Medicare revenue per 60-day completed episode(a)
$ 3,689 $ 3,698 $ (9) (0.2) %
Hospice services:
Total hospice admissions 4,805 3,783 1,022 27.0 %
Average daily census 5,199 3,794 1,405 37.0 %
Hospice Medicare revenue per day $ 192 $ 190 $ 2 1.1 %
Three Months Ended March 31,
2026 2025 Change % Change
Same agency(b) results:
Home health and hospice revenue $ 159,917 $ 143,949 $ 15,968 11.1 %
Home health services:
Total home health admissions 18,264 17,268 996 5.8 %
Total Medicare home health admissions 7,693 7,048 645 9.2 %
Average Medicare revenue per 60-day completed episode(a)
$ 3,782 $ 3,706 $ 76 2.1 %
Hospice services:
Total hospice admissions 3,579 3,534 45 1.3 %
Average daily census 3,952 3,585 367 10.2 %
Hospice Medicare revenue per day $ 189 $ 183 $ 6 3.3 %
The following table summarizes our senior living performance indicators for the periods indicated:
Three Months Ended March 31,
2026 2025 Change % Change
Total senior living results:
Senior living revenue $ 56,275 $ 49,972 $ 6,303 12.6 %
Occupancy 78.6 % 78.5 % 0.1 %
Average monthly revenue per occupied unit $ 5,388 $ 5,193 $ 195 3.8 %
8
Three Months Ended March 31,
2026 2025 Change % Change
Same store senior living(a) results:
Senior living revenue $ 51,550 $ 47,969 $ 3,581 7.5 %
Occupancy 81.0 % 79.2 % 1.8 %
Average monthly revenue per occupied unit $ 5,378 $ 5,093 $ 285 5.6 %
9
THE PENNANT GROUP, INC.
REVENUE BY PAYOR SOURCE
(unaudited, dollars in thousands)
The following table presents our total revenue by payor source as a percentage of total revenue for the periods indicated:
Three Months Ended March 31,
2026 2025
Revenue Dollars Revenue Percentage Revenue Dollars Revenue Percentage
Revenue:
Medicare $ 144,858 50.8 % $ 101,125 48.2 %
Medicaid 37,321 13.1 27,338 13.0
Subtotal 182,179 63.9 128,463 61.2
Managed care 45,727 16.0 30,714 14.6
Private and other(a)
57,458 20.1 50,665 24.2
Total revenue $ 285,364 100.0 % $ 209,842 100.0 %
(a) Private and other payors includes revenue from all payors generated in the Company’s home care operations and management services agreement.
10
THE PENNANT GROUP, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION
(unaudited, in thousands, except per share data)
The following table reconciles net income to Non-GAAP net income for the periods presented:
Three Months Ended March 31,
2026 2025
Net income attributable to The Pennant Group, Inc. $ 8,519 $ 7,775
Non-GAAP adjustments
Costs at start-up operations(a)
539 93
Share-based compensation expense(b)
2,589 2,167
Acquisition related costs(c)
354 272
Activities associated with transitioning operations(d)
— 75
Transition services costs(e)
407 —
Unusual, non-recurring or redundant charges(f)
— 51
Provision for income taxes on Non-GAAP adjustments(g)
(880) (809)
Non-GAAP net income $ 11,528 $ 9,624
Dilutive Earnings Per Share As Reported
Net Income $ 0.24 $ 0.22
Average number of shares outstanding 35,757 35,202
Adjusted Diluted Earnings Per Share
Net Income $ 0.32 $ 0.27
Average number of shares outstanding 35,757 35,202
(a) Represents results related to start-up operations.
Three Months Ended March 31,
2026 2025
Revenue $ (1,877) $ (865)
Cost of services 2,172 943
Rent 68 7
Depreciation & amortization 176 8
Total Non-GAAP adjustment $ 539 $ 93
(b) Represents share-based compensation expense incurred for the periods presented.
Three Months Ended March 31,
2026 2025
Cost of services $ 1,418 $ 1,195
General and administrative 1,171 972
Total Non-GAAP adjustment $ 2,589 $ 2,167
(c) Represents costs incurred to acquire an operation that are not capitalizable.
11
(d) During 2025, an affiliate of the Company held its memory care units in transition and is converting the facility into an assisted living community.
Three Months Ended March 31,
2026 2025
Cost of services $ — $ 20
Rent — 52
Depreciation — 3
Total Non-GAAP adjustment $ — $ 75
(e) Costs identified as redundant or non-recurring incurred by the Company as a result of the transition services agreement between the Company and UnitedHealth Group Incorporated entered into as part of the acquisition agreement consummated on October 1, 2025. All amounts are included in Cost of services. Fees incurred under the transition services agreement were $2,815 for the three months ended March 31, 2026.
(f) Represents other unusual, non-recurring, or redundant charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
(g)
Represents an adjustment to the provision for income tax to the year-to-date effective tax rate of 26.0% and 26.1% for the three months ended March 31, 2026 and 2025, respectively. This rate excludes the tax benefit of share-based payment awards.
The table below reconciles Consolidated net income to the Consolidated Non-GAAP financial measure, Consolidated Adjusted EBITDA, and to the Non-GAAP valuation measure, Consolidated Adjusted EBITDAR, for the periods presented:
Three Months Ended March 31,
2026 2025
Consolidated net income
$ 10,293 $ 8,522
Less: Net income attributable to noncontrolling interest 1,774 747
Add: Provision for income taxes
3,794 2,854
Net interest expense 3,068 1,205
Depreciation and amortization 2,616 1,892
Consolidated EBITDA 17,997 13,726
Adjustments to Consolidated EBITDA
Add: Start-up operations(a)
295 78
Share-based compensation expense(b)
2,589 2,167
Acquisition related costs(c)
354 272
Activities associated with transitioning operations(d)
— 20
Transition services costs(e)
407 —
Other unusual, non-recurring, or redundant charges(f)
— 51
Rent related to items (a) and (d) above 68 59
Consolidated Adjusted EBITDA 21,710 16,373
Rent—cost of services 13,098 11,715
Rent related to items (a) and (d) above (68) (59)
Adjusted rent—cost of services 13,030 11,656
Consolidated Adjusted EBITDAR(g)
$ 34,740
12
(a) Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations.
(b) Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.
(c) Non-capitalizable costs associated with acquisitions and write-offs for amounts in dispute with the prior owners of certain acquired operations.
(d) During 2025, an affiliate of the Company held its memory care units in transition and is converting the facility into an assisted living community.
(e) Costs identified as redundant or non-recurring incurred by the Company as a result of the transition services agreement between the Company and UnitedHealth Group Incorporated entered into as part of the acquisition agreement consummated on October 1, 2025. All amounts are included in Cost of services. Fees incurred under the transition services agreement were $2,815 for the three months ended March 31, 2026.
(f)
Represents other unusual, non-recurring, or redundant charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
(g) This measure is a valuation measure and is displayed thusly, it is not a performance measure as it excludes rent expense, which is a normal and recurring operating expense and, as such, does not reflect our cash requirements for leasing commitments. Our presentation of Consolidated Adjusted EBITDAR should not be construed as a financial performance measure.
The table below reconciles Consolidated net income attributable to The Pennant Group, Inc. to the Consolidated Non-GAAP financial measures, Consolidated Adjusted EBITDA and Consolidated Adjusted EBITDA prior to NCI, for the periods presented:
Three Months Ended March 31,
2026 2025
Net income attributable to The Pennant Group, Inc. $ 8,519 $ 7,775
Add: Provision for income taxes
3,794 2,854
Net interest expense 3,068 1,205
Depreciation and amortization 2,616 1,892
Consolidated EBITDA 17,997 13,726
Adjustments to Consolidated EBITDA
Add: Start-up operations(a)
295 78
Share-based compensation expense(b)
2,589 2,167
Acquisition related costs(c)
354 272
Activities associated with transitioning operations(d)
— 20
Transition services costs(e)
407 —
Other unusual, non-recurring, or redundant charges(f)
— 51
Rent related to items (a) and (d) above 68 59
Consolidated Adjusted EBITDA 21,710 16,373
Add: Net Income attributable to noncontrolling interest (“NCI”) 1,774 747
Consolidated Adjusted EBITDA prior to NCI $ 23,484 $ 17,120
(a) Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations.
(b) Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.
(c) Non-capitalizable costs associated with acquisitions and write-offs for amounts in dispute with the prior owners of certain acquired operations.
(d) During 2025, an affiliate of the Company held its memory care units in transition and is converting the facility into an assisted living community.
(e) Costs identified as redundant or non-recurring incurred by the Company as a result of the transition services agreement between the Company and UnitedHealth Group Incorporated entered into as part of the acquisition agreement consummated on October 1, 2025. All amounts are included in Cost of services. Fees incurred under the transition services agreement were $2,815 for the three months ended March 31, 2026.
(f)
Represents other unusual, non-recurring, or redundant charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
13
The following tables present certain financial information regarding our reportable segments. General and administrative expenses are not allocated to the reportable segments:
Home Health and Hospice Services Senior Living Services All Other Total
Three Months Ended March 31, 2026
Revenue $ 228,832 $ 54,654 $ 1,878 $ 285,364
Segment Cost of Services 192,031 38,390
Segment Adjusted EBITDAR from Operations $ 36,801 $ 16,264 $ 53,065
Three Months Ended March 31, 2025
Revenue $ 159,443 $ 49,534 $ 865 $ 209,842
Segment Cost of Services 132,169 35,085
Segment Adjusted EBITDAR from Operations $ 27,274 $ 14,449 $ 41,723
The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations:
Three Months Ended March 31,
2026 2025
Segment Adjusted EBITDAR from Operations(a)
$ 53,065 $ 41,723
Less: Unallocated corporate expenses 18,325 13,694
Less: Depreciation and amortization 2,616 1,892
Rent—cost of services 13,098 11,715
Other income (146) (69)
Adjustments to Segment EBITDAR from Operations:
Less: Start-up operations(b)
295 78
Share-based compensation expense(c)
2,589 2,167
Acquisition related costs(d)
354 272
Activities associated with transitioning operations(e)
— 20
Transition services costs(f)
407 —
Other unusual, non-recurring, or redundant charges(g)
— 51
Add: Net income attributable to noncontrolling interest
1,774 747
Income from operations $ 17,301 $ 12,650
(a)
Segment Adjusted EBITDAR from Operations is net income attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, unallocated corporate and administrative expenses, and, in order to view the operations’ performance on a comparable basis from period to period, certain adjustments including: (1) activities associated with start-up operations, (2) share-based compensation expense, (3) acquisition related costs, (4) activities associated with transitioning operations, (5) transition services costs, (6) other unusual, non-recurring, or redundant charges, and (7) net income attributable to noncontrolling interest. “All Other” consists of revenues generated at operating locations not included in the segment financial information reviewed by the CODM. Revenue included in the “All Other” category is insignificant individually, and therefore does not constitute a reportable segment. General and administrative expenses are not allocated to the reportable segments, and are included as “Unallocated corporate expenses”, accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited.
(b) Represents results related to start-up operations. This amount excludes rent and depreciation and amortization expense related to such operations.
(c) Share-based compensation expense and related payroll taxes incurred. Share-based compensation expense and related payroll taxes are included in cost of services and general and administrative expense.
(d) Non-capitalizable costs associated with acquisitions and write-offs for amounts in dispute with the prior owners of certain acquired operations.
(e) During 2025, an affiliate of the Company held its memory care units in transition and is converting the facility into an assisted living community.
14
(f) Costs identified as redundant or non-recurring incurred by the Company as a result of the transition services agreement between the Company and UnitedHealth Group Incorporated entered into as part of the acquisition agreement consummated on October 1, 2025. All amounts are included in Cost of services. Fees incurred under the transition services agreement were $2,815 for the three months ended March 31, 2026.
(g) Represents other unusual, non-recurring, or redundant charges for legal services, implementation costs, integration costs, and consulting fees in general and administrative and cost of services expenses.
The tables below reconcile Segment Adjusted EBITDAR from Operations to Segment Adjusted EBITDA from Operations for each reportable segment for the periods presented:
Three Months Ended March 31,
Home Health and Hospice Senior Living
2026 2025 2026 2025
Segment Adjusted EBITDAR from Operations $ 36,801 $ 27,274 $ 16,264 $ 14,449
Less: Rent—cost of services 3,214 2,142 9,885 9,573
Rent related to start-up and transitioning operations (13) (7) (55) (52)
Segment Adjusted EBITDA from Operations $ 33,600 $ 25,139 $ 6,434 $ 4,928
15
Discussion of Non-GAAP Financial Measures
EBITDA consists of net income, adjusted for net income attributable to noncontrolling interest (“NCI”), before (a) interest expense, net, (b) provisions for income taxes, and (c) depreciation and amortization. Adjusted EBITDA consists of net income attributable to the Company before (a) interest expense, net (b) provisions for income taxes, (c) depreciation and amortization, (d) results related to start-up operations, including rent and excluding depreciation, interest and income taxes, (e) share-based compensation expense, (f) non-capitalizable acquisition related costs, (g) activities associated with transitioning operations, (h) transition services costs, and (i) other unusual, non-recurring or redundant charges. Adjusted EBITDA prior to NCI consists of net income attributable to the Company before (a) interest expense, net (b) provisions for income taxes, (c) depreciation and amortization, (d) results related to start-up operations, (f) non-capitalizable acquisition related costs, (g) activities associated with transitioning operations, (h) transition services costs, (i) unusual, non-recurring or redundant charges, and (j) NCI. Consolidated Adjusted EBITDAR is a valuation measure applicable to current periods only and consists of net income attributable to the Company before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, (d) rent-cost of services, (e) results related to start-up operations, excluding rent, depreciation, interest and income taxes, (f) share-based compensation expense, (g) acquisition related costs, (h) activities associated with transitioning operations, (i) transition services costs, and (j) other unusual, non-recurring or redundant charges. The company believes that the presentation of EBITDA, adjusted EBITDA, adjusted EBITDA prior to NCI, consolidated adjusted EBITDAR, adjusted net income, and adjusted earnings per share provides important supplemental information to management and investors to evaluate the company’s operating performance. The company believes disclosure of adjusted net income, adjusted net income per share, EBITDA, adjusted EBITDA, adjusted EBITDA prior to NCI, and consolidated adjusted EBITDAR has economic substance because the excluded revenues and expenses are infrequent in nature and are variable in nature, or do not represent current revenues or cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the company believes that this non-GAAP measure provides useful information to investors, the specific manner in which management uses this measure, and some of the limitations associated with the use of this measure, please refer to the company's periodic filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Report on Form 10-Q. The company’s periodic filings are available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Pennant’s website at http://www.pennantgroup.com.
16
GRAPHIC
GRAPHIC
Filename: pennantlogoa01a.jpg · Sequence: 6
Binary file (24818 bytes)
Download pennantlogoa01a.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 8
v3.26.1
Cover Page
May 06, 2026
Cover [Abstract]
Document Type
8-K
Document Period End Date
May 06, 2026
Entity Registrant Name
The Pennant Group, Inc.
Entity Incorporation, State or Country Code
DE
Entity File Number
001-38900
Entity Tax Identification Number
83-3349931
Entity Address, Address Line One
1675 E Riverside Drive
Entity Address, Address Line Two
Suite 150
Entity Address, City or Town
Eagle
Entity Address, State or Province
ID
Entity Address, Postal Zip Code
83616
City Area Code
208
Local Phone Number
401-1400
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common Stock, par value $0.001 per share
Trading Symbol
PNTG
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
false
Entity Central Index Key
0001766400
Amendment Flag
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration